European Companies Search Engine
EU funding (€1,904,544): ulTRafast hOlograPHic FTIR microscopY Hor28 Jul 2022 EU Research and Innovation programme "Horizon"
Overview
Text
ulTRafast hOlograPHic FTIR microscopY
Many human pathologies such as cancer are due to complex biochemical alterations that start at a sub-cellular level and lead to progressive changes that result in a heterogeneous tumor composition. The polyclonality of tumor cells hampers the diagnosis and the therapy giving rise to tumor clones that lead to therapy resistance and promote metastases. An accurate diagnosis of tumor biopsies to identify these particular cell clones is crucial to provide targeted therapy tailored to the tumor characteristics, to improve the patient outcomes and increase survival rates. For this vision to come true, we introduce ulTRafast hOlograPHic FT-IR microscopY (TROPHY) as a paradigm shift in vibrational microscopy, blending elements of photo-thermal infrared (PT-IR), Fourier transform (FT)-IR, and Digital Holography Microscopy (DHM). TROPHY brings these techniques to the unprecedented ultrafast timescale, where the refractive index change induced by coherent IR vibrations is probed at its peak value before thermal relaxation. TROPHY borrows from PT-IR the combination of IR vibrational excitation with visible probing for high spatial resolution, from FT-IR the use of time-domain interferometry to obtain a high spectral resolution from broadband excitation, from DHM highly sensitive and quantitative detection of the refractive index (phase) change. Combined with artificial intelligence algorithms, this technology will enable quantitative concentration imaging of molecular biomarkers with high spatial resolution, high chemical selectivity and high speed, with a transformative impact on medical research and clinics. In oncology, it will be applied to intraoperative diagnosis of tumor biopsies, providing tumor grading, staging and subtyping, and supporting complete tumor resection. It will also allow to determine the best therapeutic approach tailored to the patient and identify resistant tumor clones under targeted therapy, paving the way for precision medicine in cancer.
Funded Companies:
| Company name | Funding amount |
| LYNCEE TEC SA | ? |
| Consiglio Nazionale Delle Ricerche | €397,841 |
| Fundacio Institut de Ciencies Fotoniques | €399,700 |
| Politecnico Di Milano | €740,625 |
| UNIVERSITATSKLINIKUM JENA | €366,378 |
Source: https://cordis.europa.eu/project/id/101047137
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Lyncée Tec SA, Ecublens, Switzerland.
The visualizations for "LYNCEE TEC SA - EU funding (€1,904,544): ulTRafast hOlograPHic FTIR microscopY"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
